Cytostatic effect of novel mTOR inhibitor, PRP-1 (galarmin) in MDA 231 (ER?) breast carcinoma cell line. PRP-1 inhibits mesenchymal tumors

Karina A. Galoian, Thomas H. Temple, Armen Galoyan

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Cytostatic effect of novel mTOR inhibitor, PRP-1 (galarmin) in MDA 231 (ER?) breast carcinoma cell line. PRP-1 inhibits mesenchymal tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences